[HTML][HTML] Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in …
Background Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR)
predict for survival in cancer patients. In patients receiving multimodality therapy, the effect of …
predict for survival in cancer patients. In patients receiving multimodality therapy, the effect of …
The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies
T Wang, J Yu, M Liu, Y Chen, C Zhu, L Lu… - Drug Design …, 2019 - Taylor & Francis
Purpose Fluoropyrimidine plus platinum (FP) is currently the standard treatment for
esophageal cancer (EC). In recent years, taxane-based chemotherapy has also been used …
esophageal cancer (EC). In recent years, taxane-based chemotherapy has also been used …
Comparison of efficacy and safety of taxanes plus platinum and fluorouracil plus platinum in the first-line treatment of esophageal cancer: a systematic review and …
Y Zhao, R Song, Y Jia, X Zhang, S Zhang, C Wu… - Current …, 2022 - mdpi.com
Fluoropyrimidine plus platinum (FP) and taxanes plus platinum (TP) are standard treatments
for esophageal cancer (EC). This systematic review and meta-analysis aim to explore the …
for esophageal cancer (EC). This systematic review and meta-analysis aim to explore the …
Primary gross tumor volume is an important prognostic factor in locally advanced esophageal cancer patients treated with trimodality therapy
Purpose This study investigated the relationship between tumor volume and outcomes in
patients receiving trimodality therapy for locally advanced esophageal cancer. Methods …
patients receiving trimodality therapy for locally advanced esophageal cancer. Methods …
Comparing docetaxel plus cisplatin versus fluorouracil plus cisplatin in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy
M Xi, P Zhang, L Zhang, YD Yang, SL Liu… - Japanese journal of …, 2017 - academic.oup.com
Objective The optimal neoadjuvant chemoradiotherapy (CRT) regimen in esophageal
cancer has not yet been defined. This study was aimed to compare the differences in …
cancer has not yet been defined. This study was aimed to compare the differences in …
Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case–control …
Background To compare the clinical outcomes of neoadjuvant chemoradiotherapy (CRT)
with cisplatin/vinorelbine versus cisplatin/fluorouracil in patients with locally advanced …
with cisplatin/vinorelbine versus cisplatin/fluorouracil in patients with locally advanced …
Evaluating neoadjuvant chemotherapy for lower esophageal squamous cell carcinoma by measuring esophageal wall thickness
H Sato, K Nishikawa, T Hamakawa… - Anticancer …, 2022 - ar.iiarjournals.org
Abstract Background/Aim: The aim of this study was to evaluate the efficacy of preoperative
chemotherapy for stage II-III esophageal squamous cell carcinoma based on an objective …
chemotherapy for stage II-III esophageal squamous cell carcinoma based on an objective …